Figure S2 from Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma
Authors:
- Xuyang SongXSXuyang Song
- Robin Kate KelleyRKRobin Kate Kelley
- Anis A. KhanAKAnis A. Khan
- Nathan StandiferNSNathan Standifer
- Diansong ZhouDZDiansong Zhou
- KyoungSoo LimKLKyoungSoo Lim
- Rajesh KrishnaRKRajesh Krishna
- Lu LiuLLLu Liu
- Kun WangKWKun Wang
- Patricia McCoonPMPatricia McCoon
- Alejandra NegroANAlejandra Negro
- Philip HePHPhilip He
Open Access
- 1 April 2023
- other
- Published by American Association for Cancer Research (AACR)